Clinical Study
Circulating Anti-PLAC1 Antibodies during Pregnancy and in Women with Reproductive Failure: A Preliminary Analysis
Table 2
Pregnancy outcomes of the women included in the study.
| | Women negative for antiPLAC1 ()* | Women positive for antiPLAC1 () |
| | Preeclampsia | 4 (5%) | 0 | | Maternal PIH | 10 (12%) | 0 | | Preterm labor | 1 (1.2%) | 0 | | Fetal distress | 3 (3.5%) | 0 | | Chorioamnionitis | 5 (6%) | 0 | | Gestational diabetes | 7 (8%) | 1 | | IUGR | 0 | 0 | | Clotting abnormalities | 2 (2.4) | 0 |
|
|
*Outcomes missing in 17 patients due to loss of follow-up or pending deliveries.
|
